Induction of acute silkworm hemolymph melanization by Staphylococcus aureus treated with peptidoglycan-degrading enzymes.

Staphylococcus aureus innate immunity melanization silkworm

Journal

Drug discoveries & therapeutics
ISSN: 1881-784X
Titre abrégé: Drug Discov Ther
Pays: Japan
ID NLM: 101493809

Informations de publication

Date de publication:
26 Jun 2024
Historique:
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 26 6 2024
Statut: aheadofprint

Résumé

Staphylococcus aureus, a Gram-positive bacterium, causes inflammatory skin diseases, such as atopic dermatitis, and serious systemic diseases, such as sepsis. In the skin and nasal environment, peptidoglycan (PGN)-degrading enzymes, including lysozyme and lysostaphin, affects S. aureus PGN. However, the effects of PGN-degrading enzymes on the acute innate immune-inducing activity of S. aureus have not yet been investigated. In this study, we demonstrated that PGN-degrading enzymes induce acute silkworm hemolymph melanization by S. aureus. Insoluble fractions of S. aureus treated with lysozyme, lysostaphin, or both enzymes, were prepared. Melanization of the silkworm hemolymph caused by the injection of these insoluble fractions was higher than that of S. aureus without enzyme treatment. These results suggest that structural changes in S. aureus PGN caused by PGN-degrading enzymes affect the acute innate immune response in silkworms.

Identifiants

pubmed: 38925960
doi: 10.5582/ddt.2024.01026
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yasuhiko Matsumoto (Y)

Department of Microbiology, Meiji Pharmaceutical University, Tokyo, 204-8588, Japan.

Eri Sato (E)

Department of Microbiology, Meiji Pharmaceutical University, Tokyo, 204-8588, Japan.

Takashi Sugita (T)

Department of Microbiology, Meiji Pharmaceutical University, Tokyo, 204-8588, Japan.

Classifications MeSH